Chemring Declines Takeover Bid: A Good Choice
2025-03-25 19:40:44 ET
Summary
- Chemring Group's stock has significant upside potential due to European rearmament and preference for local contractors, driving M&A activity.
- Bain Capital's $1.4 billion offer for Chemring was rejected as it undervalued the company, lacking a 30% premium and future growth considerations.
- My updated price target for Chemring is $5.50, reflecting increased capex and investments, yet still indicating Bain's offer was inadequate.
- I maintain a buy rating for Chemring, expecting a $6.45 price target by FY 2026, with any acquisition offer needing to be around $7.15.
I covered Chemring Group ( OTCPK:CMGMY ) in December 2024 with a buy rating . I believe that the stock has upward potential driven by the rearmament of European countries with an increasing focus on procuring from European contractors where possible....
Read the full article on Seeking Alpha
For further details see:
Chemring Declines Takeover Bid: A Good ChoiceNASDAQ: CMGMY
CMGMY Trading
6.71% G/L:
$7.79 Last:
78,944 Volume:
$8 Open:



